About Enhancer
| Enhancer ID: | E_02895 |
| Species: | Homo sapiens |
| Position : | chr2:85750614-85811383   |
| Year: | 2016 |
| Title: | Chromatin interactions and candidate genes at ten prostate cancer risk loci. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26979803 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | LCL-32370 |
| Experiment Type: | Chromatin interaction assay; TF binding assay; Gene expression assay |
| High Throughput Method: | Capture 3C-seq; ChIP-seq; RNA-seq; SNP genotyping array; 3C; eQTL analysis |
| Low Throughput Method: | 3C-qPCR; RT-qPCR |
About Target Gene
| Target gene : | NA |
About TF
| TF name : | AR |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| AR | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | reactome | 65 |
| AR | Alpha6Beta4Integrin | netpath | 74 |
| AR | AndrogenReceptor | netpath | 167 |
| AR | Coregulation of Androgen receptor activity | pid | 61 |
| AR | FOXA1 transcription factor network | pid | 45 |
| AR | IL6 | netpath | 85 |
| AR | Nongenotropic Androgen signaling | pid | 31 |
| AR | Notch-mediated HES/HEY network | pid | 48 |
| AR | Nuclear Receptor transcription pathway | reactome | 51 |
| AR | Regulation of Androgen receptor activity | pid | 54 |
| AR | Regulation of nuclear beta catenin signaling and target gene transcription | pid | 80 |
| AR | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| AR | TGF_beta_Receptor | netpath | 220 |
| AR | Oocyte meiosis | kegg | 110 |
| AR | Pathways in cancer | kegg | 321 |
| AR | Prostate cancer | kegg | 85 |
| AR | Hs_DNA_Damage_Response_WP707_82937 | wikipathways | 28 |
| AR | Hs_miRNA_Regulation_of_DNA_Damage_Response_WP1530_84694 | wikipathways | 28 |
| AR | Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 | wikipathways | 122 |
| AR | Hs_Sudden_Infant_Death_Syndrome_(SIDS)_Susceptibility_Pathways_WP706_86078 | wikipathways | 33 |
| AR | Hs_Androgen_receptor_signaling_pathway_WP138_79958 | wikipathways | 27 |
Enhancer Associated Network
Overlapping Enhancers (hg19)
23 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02854 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02855 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02856 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02857 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02870 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02871 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02872 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02873 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02893 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02894 | chr2:85750614-85811383 | blood | NA | NA |
| E_02896 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02897 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02898 | chr2:85750614-85811383 | blood | NA | NA |
| E_02899 | chr2:85750614-85811383 | blood | NA | NA |
| E_02900 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02901 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02902 | chr2:85750614-85811383 | blood | NA | NA |
| E_02903 | chr2:85750614-85811383 | blood | NA | NA |
| E_02904 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02905 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02906 | chr2:85750614-85811383 | blood | NA | NA |
| E_02907 | chr2:85750614-85811383 | blood | NA | NA |
| E_02908 | chr2:85750614-85811383 | prostate gland | NA | NA |
Expression of Target Genes for the Enhancer